PLoS One-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=953722, encodeId=f22c953e2248, content=投稿半个月了，还是Manuscript Submitted to Journal这个状态，需要发邮件问一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Sun Apr 04 09:39:59 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210396, encodeId=3194121039613, content=**次投这个杂志，需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:41:13 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210398, encodeId=35e4121039804, content=请问各位大佬，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:42:00 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062547, encodeId=990a106254ecd, content=想问一下各位前辈，投稿到发表全过程，期刊会要求上传原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c5d5530921, createdName=ms4000000917868696, createdTime=Thu Oct 21 11:38:57 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911210, encodeId=4a9d911210b6, content=求教一下各位大佬，我投稿到最后一步，让我点I accept，勾上后就没有下一步了，然后稿件一直处于Submissions Waiting for Author's Approval，求教大佬指点一下，应该怎么搞，万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75325447951, createdName=ms8000001411811314, createdTime=Sun Dec 27 10:27:14 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196337, encodeId=9b35119633ed6, content=偏重的研究方向：肿瘤 经验分享：请问各位接收后什么时候交版面费么，看有的伙伴没交钱直接online了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Wed Feb 23 09:59:25 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225537, encodeId=ede1122553ea4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学;肿瘤 经验分享：中了一篇，没通知版面费，校稿后就online了，啥情况这是？我好懵啊，这杂志不用版面费也能OA了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=ms6000000505814461, createdTime=Thu Jun 09 22:39:03 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082083, encodeId=0984108208379, content=大家好，我的一篇文章被接收了，但是这个杂志被首医列为预警名单了，另外版面费要1万多人民币，单位不报销，奖励也没有，我要不要撤稿啊，如果撤稿了对投其他杂志有没有影响啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01fd2470727, createdName=124386b4m57(暂无昵称), createdTime=Mon Dec 20 14:31:28 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213864, encodeId=be0812138642b, content=请问大家Clinical Studies Checklist在哪里下载，我怎么没找到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Sun Apr 24 11:18:48 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209577, encodeId=f07f12095e792, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：333 经验分享：44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gjR5H01q089ibicoupdmf2tYdbfx3hPL6fxbMS7NM9dEvaicANS4rACp1aDmDDsuQs8fqqXJrNruPvNLfuuAEVPWQ/132, createdBy=5cb72530807, createdName=伍达辉, createdTime=Fri Apr 08 14:57:28 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2021-04-04 122e6881m72暂无昵称

投稿半个月了，还是Manuscript Submitted to Journal这个状态，需要发邮件问一下吗？

123 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=953722, encodeId=f22c953e2248, content=投稿半个月了，还是Manuscript Submitted to Journal这个状态，需要发邮件问一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Sun Apr 04 09:39:59 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210396, encodeId=3194121039613, content=**次投这个杂志，需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:41:13 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210398, encodeId=35e4121039804, content=请问各位大佬，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:42:00 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062547, encodeId=990a106254ecd, content=想问一下各位前辈，投稿到发表全过程，期刊会要求上传原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c5d5530921, createdName=ms4000000917868696, createdTime=Thu Oct 21 11:38:57 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911210, encodeId=4a9d911210b6, content=求教一下各位大佬，我投稿到最后一步，让我点I accept，勾上后就没有下一步了，然后稿件一直处于Submissions Waiting for Author's Approval，求教大佬指点一下，应该怎么搞，万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75325447951, createdName=ms8000001411811314, createdTime=Sun Dec 27 10:27:14 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196337, encodeId=9b35119633ed6, content=偏重的研究方向：肿瘤 经验分享：请问各位接收后什么时候交版面费么，看有的伙伴没交钱直接online了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Wed Feb 23 09:59:25 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225537, encodeId=ede1122553ea4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学;肿瘤 经验分享：中了一篇，没通知版面费，校稿后就online了，啥情况这是？我好懵啊，这杂志不用版面费也能OA了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=ms6000000505814461, createdTime=Thu Jun 09 22:39:03 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082083, encodeId=0984108208379, content=大家好，我的一篇文章被接收了，但是这个杂志被首医列为预警名单了，另外版面费要1万多人民币，单位不报销，奖励也没有，我要不要撤稿啊，如果撤稿了对投其他杂志有没有影响啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01fd2470727, createdName=124386b4m57(暂无昵称), createdTime=Mon Dec 20 14:31:28 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213864, encodeId=be0812138642b, content=请问大家Clinical Studies Checklist在哪里下载，我怎么没找到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Sun Apr 24 11:18:48 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209577, encodeId=f07f12095e792, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：333 经验分享：44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gjR5H01q089ibicoupdmf2tYdbfx3hPL6fxbMS7NM9dEvaicANS4rACp1aDmDDsuQs8fqqXJrNruPvNLfuuAEVPWQ/132, createdBy=5cb72530807, createdName=伍达辉, createdTime=Fri Apr 08 14:57:28 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2022-04-11 weizi7539

**次投这个杂志，需要原始数据吗

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=953722, encodeId=f22c953e2248, content=投稿半个月了，还是Manuscript Submitted to Journal这个状态，需要发邮件问一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Sun Apr 04 09:39:59 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210396, encodeId=3194121039613, content=**次投这个杂志，需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:41:13 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210398, encodeId=35e4121039804, content=请问各位大佬，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:42:00 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062547, encodeId=990a106254ecd, content=想问一下各位前辈，投稿到发表全过程，期刊会要求上传原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c5d5530921, createdName=ms4000000917868696, createdTime=Thu Oct 21 11:38:57 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911210, encodeId=4a9d911210b6, content=求教一下各位大佬，我投稿到最后一步，让我点I accept，勾上后就没有下一步了，然后稿件一直处于Submissions Waiting for Author's Approval，求教大佬指点一下，应该怎么搞，万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75325447951, createdName=ms8000001411811314, createdTime=Sun Dec 27 10:27:14 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196337, encodeId=9b35119633ed6, content=偏重的研究方向：肿瘤 经验分享：请问各位接收后什么时候交版面费么，看有的伙伴没交钱直接online了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Wed Feb 23 09:59:25 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225537, encodeId=ede1122553ea4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学;肿瘤 经验分享：中了一篇，没通知版面费，校稿后就online了，啥情况这是？我好懵啊，这杂志不用版面费也能OA了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=ms6000000505814461, createdTime=Thu Jun 09 22:39:03 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082083, encodeId=0984108208379, content=大家好，我的一篇文章被接收了，但是这个杂志被首医列为预警名单了，另外版面费要1万多人民币，单位不报销，奖励也没有，我要不要撤稿啊，如果撤稿了对投其他杂志有没有影响啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01fd2470727, createdName=124386b4m57(暂无昵称), createdTime=Mon Dec 20 14:31:28 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213864, encodeId=be0812138642b, content=请问大家Clinical Studies Checklist在哪里下载，我怎么没找到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Sun Apr 24 11:18:48 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209577, encodeId=f07f12095e792, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：333 经验分享：44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gjR5H01q089ibicoupdmf2tYdbfx3hPL6fxbMS7NM9dEvaicANS4rACp1aDmDDsuQs8fqqXJrNruPvNLfuuAEVPWQ/132, createdBy=5cb72530807, createdName=伍达辉, createdTime=Fri Apr 08 14:57:28 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2022-04-11 weizi7539

请问各位大佬，这个杂志需要原始数据吗？

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=953722, encodeId=f22c953e2248, content=投稿半个月了，还是Manuscript Submitted to Journal这个状态，需要发邮件问一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Sun Apr 04 09:39:59 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210396, encodeId=3194121039613, content=**次投这个杂志，需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:41:13 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210398, encodeId=35e4121039804, content=请问各位大佬，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:42:00 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062547, encodeId=990a106254ecd, content=想问一下各位前辈，投稿到发表全过程，期刊会要求上传原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c5d5530921, createdName=ms4000000917868696, createdTime=Thu Oct 21 11:38:57 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911210, encodeId=4a9d911210b6, content=求教一下各位大佬，我投稿到最后一步，让我点I accept，勾上后就没有下一步了，然后稿件一直处于Submissions Waiting for Author's Approval，求教大佬指点一下，应该怎么搞，万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75325447951, createdName=ms8000001411811314, createdTime=Sun Dec 27 10:27:14 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196337, encodeId=9b35119633ed6, content=偏重的研究方向：肿瘤 经验分享：请问各位接收后什么时候交版面费么，看有的伙伴没交钱直接online了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Wed Feb 23 09:59:25 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225537, encodeId=ede1122553ea4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学;肿瘤 经验分享：中了一篇，没通知版面费，校稿后就online了，啥情况这是？我好懵啊，这杂志不用版面费也能OA了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=ms6000000505814461, createdTime=Thu Jun 09 22:39:03 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082083, encodeId=0984108208379, content=大家好，我的一篇文章被接收了，但是这个杂志被首医列为预警名单了，另外版面费要1万多人民币，单位不报销，奖励也没有，我要不要撤稿啊，如果撤稿了对投其他杂志有没有影响啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01fd2470727, createdName=124386b4m57(暂无昵称), createdTime=Mon Dec 20 14:31:28 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213864, encodeId=be0812138642b, content=请问大家Clinical Studies Checklist在哪里下载，我怎么没找到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Sun Apr 24 11:18:48 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209577, encodeId=f07f12095e792, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：333 经验分享：44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gjR5H01q089ibicoupdmf2tYdbfx3hPL6fxbMS7NM9dEvaicANS4rACp1aDmDDsuQs8fqqXJrNruPvNLfuuAEVPWQ/132, createdBy=5cb72530807, createdName=伍达辉, createdTime=Fri Apr 08 14:57:28 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2021-10-21 ms4000000917868696

想问一下各位前辈，投稿到发表全过程，期刊会要求上传原始数据吗？

76 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=953722, encodeId=f22c953e2248, content=投稿半个月了，还是Manuscript Submitted to Journal这个状态，需要发邮件问一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Sun Apr 04 09:39:59 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210396, encodeId=3194121039613, content=**次投这个杂志，需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:41:13 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210398, encodeId=35e4121039804, content=请问各位大佬，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:42:00 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062547, encodeId=990a106254ecd, content=想问一下各位前辈，投稿到发表全过程，期刊会要求上传原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c5d5530921, createdName=ms4000000917868696, createdTime=Thu Oct 21 11:38:57 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911210, encodeId=4a9d911210b6, content=求教一下各位大佬，我投稿到最后一步，让我点I accept，勾上后就没有下一步了，然后稿件一直处于Submissions Waiting for Author's Approval，求教大佬指点一下，应该怎么搞，万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75325447951, createdName=ms8000001411811314, createdTime=Sun Dec 27 10:27:14 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196337, encodeId=9b35119633ed6, content=偏重的研究方向：肿瘤 经验分享：请问各位接收后什么时候交版面费么，看有的伙伴没交钱直接online了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Wed Feb 23 09:59:25 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225537, encodeId=ede1122553ea4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学;肿瘤 经验分享：中了一篇，没通知版面费，校稿后就online了，啥情况这是？我好懵啊，这杂志不用版面费也能OA了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=ms6000000505814461, createdTime=Thu Jun 09 22:39:03 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082083, encodeId=0984108208379, content=大家好，我的一篇文章被接收了，但是这个杂志被首医列为预警名单了，另外版面费要1万多人民币，单位不报销，奖励也没有，我要不要撤稿啊，如果撤稿了对投其他杂志有没有影响啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01fd2470727, createdName=124386b4m57(暂无昵称), createdTime=Mon Dec 20 14:31:28 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213864, encodeId=be0812138642b, content=请问大家Clinical Studies Checklist在哪里下载，我怎么没找到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Sun Apr 24 11:18:48 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209577, encodeId=f07f12095e792, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：333 经验分享：44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gjR5H01q089ibicoupdmf2tYdbfx3hPL6fxbMS7NM9dEvaicANS4rACp1aDmDDsuQs8fqqXJrNruPvNLfuuAEVPWQ/132, createdBy=5cb72530807, createdName=伍达辉, createdTime=Fri Apr 08 14:57:28 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2020-12-27 ms8000001411811314

求教一下各位大佬，我投稿到最后一步，让我点I accept，勾上后就没有下一步了，然后稿件一直处于Submissions Waiting for Author's Approval，求教大佬指点一下，应该怎么搞，万分感谢

174 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=953722, encodeId=f22c953e2248, content=投稿半个月了，还是Manuscript Submitted to Journal这个状态，需要发邮件问一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Sun Apr 04 09:39:59 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210396, encodeId=3194121039613, content=**次投这个杂志，需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:41:13 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210398, encodeId=35e4121039804, content=请问各位大佬，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:42:00 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062547, encodeId=990a106254ecd, content=想问一下各位前辈，投稿到发表全过程，期刊会要求上传原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c5d5530921, createdName=ms4000000917868696, createdTime=Thu Oct 21 11:38:57 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911210, encodeId=4a9d911210b6, content=求教一下各位大佬，我投稿到最后一步，让我点I accept，勾上后就没有下一步了，然后稿件一直处于Submissions Waiting for Author's Approval，求教大佬指点一下，应该怎么搞，万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75325447951, createdName=ms8000001411811314, createdTime=Sun Dec 27 10:27:14 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196337, encodeId=9b35119633ed6, content=偏重的研究方向：肿瘤 经验分享：请问各位接收后什么时候交版面费么，看有的伙伴没交钱直接online了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Wed Feb 23 09:59:25 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225537, encodeId=ede1122553ea4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学;肿瘤 经验分享：中了一篇，没通知版面费，校稿后就online了，啥情况这是？我好懵啊，这杂志不用版面费也能OA了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=ms6000000505814461, createdTime=Thu Jun 09 22:39:03 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082083, encodeId=0984108208379, content=大家好，我的一篇文章被接收了，但是这个杂志被首医列为预警名单了，另外版面费要1万多人民币，单位不报销，奖励也没有，我要不要撤稿啊，如果撤稿了对投其他杂志有没有影响啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01fd2470727, createdName=124386b4m57(暂无昵称), createdTime=Mon Dec 20 14:31:28 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213864, encodeId=be0812138642b, content=请问大家Clinical Studies Checklist在哪里下载，我怎么没找到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Sun Apr 24 11:18:48 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209577, encodeId=f07f12095e792, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：333 经验分享：44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gjR5H01q089ibicoupdmf2tYdbfx3hPL6fxbMS7NM9dEvaicANS4rACp1aDmDDsuQs8fqqXJrNruPvNLfuuAEVPWQ/132, createdBy=5cb72530807, createdName=伍达辉, createdTime=Fri Apr 08 14:57:28 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2022-02-23 ms1469747388241577

偏重的研究方向：肿瘤
经验分享：请问各位接收后什么时候交版面费么，看有的伙伴没交钱直接online了呢

267 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=953722, encodeId=f22c953e2248, content=投稿半个月了，还是Manuscript Submitted to Journal这个状态，需要发邮件问一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Sun Apr 04 09:39:59 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210396, encodeId=3194121039613, content=**次投这个杂志，需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:41:13 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210398, encodeId=35e4121039804, content=请问各位大佬，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:42:00 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062547, encodeId=990a106254ecd, content=想问一下各位前辈，投稿到发表全过程，期刊会要求上传原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c5d5530921, createdName=ms4000000917868696, createdTime=Thu Oct 21 11:38:57 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911210, encodeId=4a9d911210b6, content=求教一下各位大佬，我投稿到最后一步，让我点I accept，勾上后就没有下一步了，然后稿件一直处于Submissions Waiting for Author's Approval，求教大佬指点一下，应该怎么搞，万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75325447951, createdName=ms8000001411811314, createdTime=Sun Dec 27 10:27:14 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196337, encodeId=9b35119633ed6, content=偏重的研究方向：肿瘤 经验分享：请问各位接收后什么时候交版面费么，看有的伙伴没交钱直接online了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Wed Feb 23 09:59:25 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225537, encodeId=ede1122553ea4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学;肿瘤 经验分享：中了一篇，没通知版面费，校稿后就online了，啥情况这是？我好懵啊，这杂志不用版面费也能OA了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=ms6000000505814461, createdTime=Thu Jun 09 22:39:03 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082083, encodeId=0984108208379, content=大家好，我的一篇文章被接收了，但是这个杂志被首医列为预警名单了，另外版面费要1万多人民币，单位不报销，奖励也没有，我要不要撤稿啊，如果撤稿了对投其他杂志有没有影响啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01fd2470727, createdName=124386b4m57(暂无昵称), createdTime=Mon Dec 20 14:31:28 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213864, encodeId=be0812138642b, content=请问大家Clinical Studies Checklist在哪里下载，我怎么没找到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Sun Apr 24 11:18:48 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209577, encodeId=f07f12095e792, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：333 经验分享：44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gjR5H01q089ibicoupdmf2tYdbfx3hPL6fxbMS7NM9dEvaicANS4rACp1aDmDDsuQs8fqqXJrNruPvNLfuuAEVPWQ/132, createdBy=5cb72530807, createdName=伍达辉, createdTime=Fri Apr 08 14:57:28 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2022-06-09 ms6000000505814461

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：生物信息学;肿瘤
经验分享：中了一篇，没通知版面费，校稿后就online了，啥情况这是？我好懵啊，这杂志不用版面费也能OA了吗

35 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=953722, encodeId=f22c953e2248, content=投稿半个月了，还是Manuscript Submitted to Journal这个状态，需要发邮件问一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Sun Apr 04 09:39:59 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210396, encodeId=3194121039613, content=**次投这个杂志，需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:41:13 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210398, encodeId=35e4121039804, content=请问各位大佬，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:42:00 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062547, encodeId=990a106254ecd, content=想问一下各位前辈，投稿到发表全过程，期刊会要求上传原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c5d5530921, createdName=ms4000000917868696, createdTime=Thu Oct 21 11:38:57 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911210, encodeId=4a9d911210b6, content=求教一下各位大佬，我投稿到最后一步，让我点I accept，勾上后就没有下一步了，然后稿件一直处于Submissions Waiting for Author's Approval，求教大佬指点一下，应该怎么搞，万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75325447951, createdName=ms8000001411811314, createdTime=Sun Dec 27 10:27:14 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196337, encodeId=9b35119633ed6, content=偏重的研究方向：肿瘤 经验分享：请问各位接收后什么时候交版面费么，看有的伙伴没交钱直接online了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Wed Feb 23 09:59:25 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225537, encodeId=ede1122553ea4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学;肿瘤 经验分享：中了一篇，没通知版面费，校稿后就online了，啥情况这是？我好懵啊，这杂志不用版面费也能OA了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=ms6000000505814461, createdTime=Thu Jun 09 22:39:03 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082083, encodeId=0984108208379, content=大家好，我的一篇文章被接收了，但是这个杂志被首医列为预警名单了，另外版面费要1万多人民币，单位不报销，奖励也没有，我要不要撤稿啊，如果撤稿了对投其他杂志有没有影响啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01fd2470727, createdName=124386b4m57(暂无昵称), createdTime=Mon Dec 20 14:31:28 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213864, encodeId=be0812138642b, content=请问大家Clinical Studies Checklist在哪里下载，我怎么没找到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Sun Apr 24 11:18:48 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209577, encodeId=f07f12095e792, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：333 经验分享：44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gjR5H01q089ibicoupdmf2tYdbfx3hPL6fxbMS7NM9dEvaicANS4rACp1aDmDDsuQs8fqqXJrNruPvNLfuuAEVPWQ/132, createdBy=5cb72530807, createdName=伍达辉, createdTime=Fri Apr 08 14:57:28 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2021-12-20 124386b4m57(暂无昵称)

大家好，我的一篇文章被接收了，但是这个杂志被首医列为预警名单了，另外版面费要1万多人民币，单位不报销，奖励也没有，我要不要撤稿啊，如果撤稿了对投其他杂志有没有影响啊

1 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=953722, encodeId=f22c953e2248, content=投稿半个月了，还是Manuscript Submitted to Journal这个状态，需要发邮件问一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Sun Apr 04 09:39:59 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210396, encodeId=3194121039613, content=**次投这个杂志，需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:41:13 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210398, encodeId=35e4121039804, content=请问各位大佬，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:42:00 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062547, encodeId=990a106254ecd, content=想问一下各位前辈，投稿到发表全过程，期刊会要求上传原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c5d5530921, createdName=ms4000000917868696, createdTime=Thu Oct 21 11:38:57 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911210, encodeId=4a9d911210b6, content=求教一下各位大佬，我投稿到最后一步，让我点I accept，勾上后就没有下一步了，然后稿件一直处于Submissions Waiting for Author's Approval，求教大佬指点一下，应该怎么搞，万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75325447951, createdName=ms8000001411811314, createdTime=Sun Dec 27 10:27:14 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196337, encodeId=9b35119633ed6, content=偏重的研究方向：肿瘤 经验分享：请问各位接收后什么时候交版面费么，看有的伙伴没交钱直接online了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Wed Feb 23 09:59:25 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225537, encodeId=ede1122553ea4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学;肿瘤 经验分享：中了一篇，没通知版面费，校稿后就online了，啥情况这是？我好懵啊，这杂志不用版面费也能OA了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=ms6000000505814461, createdTime=Thu Jun 09 22:39:03 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082083, encodeId=0984108208379, content=大家好，我的一篇文章被接收了，但是这个杂志被首医列为预警名单了，另外版面费要1万多人民币，单位不报销，奖励也没有，我要不要撤稿啊，如果撤稿了对投其他杂志有没有影响啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01fd2470727, createdName=124386b4m57(暂无昵称), createdTime=Mon Dec 20 14:31:28 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213864, encodeId=be0812138642b, content=请问大家Clinical Studies Checklist在哪里下载，我怎么没找到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Sun Apr 24 11:18:48 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209577, encodeId=f07f12095e792, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：333 经验分享：44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gjR5H01q089ibicoupdmf2tYdbfx3hPL6fxbMS7NM9dEvaicANS4rACp1aDmDDsuQs8fqqXJrNruPvNLfuuAEVPWQ/132, createdBy=5cb72530807, createdName=伍达辉, createdTime=Fri Apr 08 14:57:28 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2022-04-24 weizi7539

请问大家Clinical Studies Checklist在哪里下载，我怎么没找到呢？

32 0

[GetPortalCommentsPageByObjectIdResponse(id=953722, encodeId=f22c953e2248, content=投稿半个月了，还是Manuscript Submitted to Journal这个状态，需要发邮件问一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Sun Apr 04 09:39:59 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210396, encodeId=3194121039613, content=**次投这个杂志，需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:41:13 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210398, encodeId=35e4121039804, content=请问各位大佬，这个杂志需要原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Mon Apr 11 22:42:00 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062547, encodeId=990a106254ecd, content=想问一下各位前辈，投稿到发表全过程，期刊会要求上传原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c5d5530921, createdName=ms4000000917868696, createdTime=Thu Oct 21 11:38:57 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911210, encodeId=4a9d911210b6, content=求教一下各位大佬，我投稿到最后一步，让我点I accept，勾上后就没有下一步了，然后稿件一直处于Submissions Waiting for Author's Approval，求教大佬指点一下，应该怎么搞，万分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75325447951, createdName=ms8000001411811314, createdTime=Sun Dec 27 10:27:14 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196337, encodeId=9b35119633ed6, content=偏重的研究方向：肿瘤 经验分享：请问各位接收后什么时候交版面费么，看有的伙伴没交钱直接online了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Wed Feb 23 09:59:25 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225537, encodeId=ede1122553ea4, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学;肿瘤 经验分享：中了一篇，没通知版面费，校稿后就online了，啥情况这是？我好懵啊，这杂志不用版面费也能OA了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=ms6000000505814461, createdTime=Thu Jun 09 22:39:03 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082083, encodeId=0984108208379, content=大家好，我的一篇文章被接收了，但是这个杂志被首医列为预警名单了，另外版面费要1万多人民币，单位不报销，奖励也没有，我要不要撤稿啊，如果撤稿了对投其他杂志有没有影响啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=01fd2470727, createdName=124386b4m57(暂无昵称), createdTime=Mon Dec 20 14:31:28 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213864, encodeId=be0812138642b, content=请问大家Clinical Studies Checklist在哪里下载，我怎么没找到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78d71490506, createdName=weizi7539, createdTime=Sun Apr 24 11:18:48 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209577, encodeId=f07f12095e792, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：333 经验分享：44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gjR5H01q089ibicoupdmf2tYdbfx3hPL6fxbMS7NM9dEvaicANS4rACp1aDmDDsuQs8fqqXJrNruPvNLfuuAEVPWQ/132, createdBy=5cb72530807, createdName=伍达辉, createdTime=Fri Apr 08 14:57:28 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2022-04-08 伍达辉

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：333
经验分享：44

50 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务